Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07221526 · ClinicalTrials.gov registry record
SPO2 Validation Study - Philips Fast 2025
A clinical trial of Pulse Oximetry, sponsored by Philips Clinical & Medical Affairs Global.
- Recruiting
- Registry status
- 72
- Enrollment target
- 1
- Study location
NCT07221526 is a study of Pulse Oximetry that is actively recruiting participants, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 72 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07221526, a study of Pulse Oximetry, is actively recruiting participants, sponsored by Philips Clinical & Medical Affairs Global.
- RECRUITING
- Registry status
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
Clinical investigation is to validate the SpO2 accuracy of the M1133AX5, M1133AX6, and AlarX4 (nasal ala application) SpO2 sensors under test with the Philips FAST Pulse Oximetry technology.
Conditions Studied
Interventions
- DEVICE NO INTERVENTION
Study Locations (1)
Colorado
- Element Materials Technology - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2025-10-28 |
| Est. Completion | 2026-01-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07221526
The ClinicalTrials.gov registry entry for NCT07221526 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Clinical & Medical Affairs Global, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulse Oximetry appearing as the primary indexed condition, and to 1 intervention - of which NO INTERVENTION is the first listed.
NCT07221526 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT07221526 about?
NCT07221526 is a clinical study titled "SPO2 Validation Study - Philips Fast 2025". Clinical investigation is to validate the SpO2 accuracy of the M1133AX5, M1133AX6, and AlarX4 (nasal ala application) SpO2 sensors under test with the Philips FAST Pulse Oximetry technology.
What is the current status of trial NCT07221526?
This trial is currently recruiting. The enrollment target is 72 participants. The study started on 2025-10-28. Estimated completion is 2026-01-09.
What conditions does trial NCT07221526 study?
This clinical trial studies the following conditions: Pulse Oximetry.
What interventions are being tested in trial NCT07221526?
The interventions under investigation include: NO INTERVENTION (DEVICE).
Who is sponsoring clinical trial NCT07221526?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07221526 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulse Oximetry
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.